Tag: Dr. Jan Weile
Company News: Curetis and Mediphos to Sponsor Expert Discussion on the Future of Infectious Diseases Testing
– Satellite symposium will be held during the 8th European Meeting on Molecular Diagnostics (EMMD)
– Presentation of Curetis´ Unyvero™ system by distribution partner Mediphos
Curetis AG today announced it will host the satellite symposium “Molecular microbiology – the future of infectious diseases testing?” together with its Dutch distribution partner Mediphos Medical Supplies during the upcoming 8th European Meeting on Molecular Diagnostics (EMMD). The EMDD will be held from October 2 – 4, 2013, in Scheveningen, The Netherlands.
The symposium, which is scheduled for Oct. 2 from 8:30-10am (Adama Zijlstra Rooms 1 & 2), will be chaired by Prof. Paul Savelkoul (Maastricht University, The Netherlands) and Dr. Anne Thews (Curetis, Germany). Following an overview on the expectations for the future of molecular biology by Prof. Savekoul, three lectures will discuss challenges and applications: Dr. Eric Claas (LUMC Leiden, the Netherlands) is to talk about “Benefits and challenges of molecular testing in infectious diseases”. Dr. Jan Weile (Heart and Diabetes Center Bad Oeynhausen, Germany) will present “First clinical experience with the Unyvero™ P50 Pneumonia Application” and Dr. Anne Thews (Medical Director, Curetis AG) is going to discuss “Implant and tissue infections – a need for multiplexed testing?”. The subsequent panel discussion will focus on the question whether fast molecular infectious disease testing will improve patient outcome.
In addition, Mediphos Medical Supplies, the exclusive distribution partner of Curetis for The Netherlands, will present Curetis´ Unyvero™ System during the EMMD.